Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Existing law requires the State Department of Public Health to conduct various programs related to disease prevention and health promotion, including a program for identifying, screening, and providing followup care related to exposure to diethylstilbestrol while pregnant, which can cause fetal abnormalities. Existing law states the intention of the Legislature to fund this program in subsequent fiscal years through the normal budgetary process. This bill would direct, upon appropriation of funds, as specified, the State Department of Public Health, by January 1, 2028, to develop and administer a program related to drug-induced movement disorder awareness, as specified. The bill would repeal the program on January 1, 2032. The bill would include related findings and declarations.
Introduced
Feb 13, 2025
Last Action
Feb 2, 2026
Session
CA 20252026
Sponsors
1 primary · 1 co
From committee: Filed with the Chief Clerk pursuant to Joint Rule 56.
Died pursuant to Art. IV, Sec. 10(c) of the Constitution.
In committee: Held under submission.
In committee: Set, first hearing. Referred to suspense file.
Re-referred to Com. on APPR.
Read second time and amended.
From committee: Amend, and do pass as amended and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 15. Noes 0.) (April 8).
Re-referred to Com. on HEALTH.
From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended.
Referred to Com. on HEALTH.
From printer. May be heard in committee March 16.
Read first time. To print.
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
From committee: Filed with the Chief Clerk pursuant to Joint Rule 56.